Biote's acquisition of Asteria Health aims to vertically integrate manufacturing and control pharmacokinetic research. This is expected to improve margins and potentially expand therapeutic wellness products.
Just aover a week ago I gave out FREE stock picks. Let's see their updated status. $Aldeyra Therapeutics (ALDX.US)$ Since the official post (April 2nd) ALDX has increased 12% $Ardelyx (ARDX.US)$ Since the official post (April 2nd) ARDX has decreased -4% $biote (BTMD.US)$ Since the official post (April 2nd) BTMD has increased 3% $CompoSecure (CMPO.US)$ Since the official post (April 2nd) ALDX has increased 8% TOTAL: 19% increase in 6 tot...
Alexander Legaux : @Jaguar8 I really like your quick blurbs about companies. it gives me an idea of what to research if I like what I read. Thank you.